Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Cited by (1,007)

Items 501–600 of 1,007

1. Noninvasive estimation of fibrosis progression overtime using the FIB‐4 index in chronic hepatitis C
   Nobuharu Tamaki, Masayuki Kurosaki, K. Tanaka, Yoichi Suzuki, Yoshihide Hoshioka, Takayuki Kato, Yutaka Yasui, T. Hosokawa, Kazuhiko Ueda, Kaoru Tsuchiya et al. · 2012 · Journal of Viral Hepatitis
2. Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection
   Stefania Varchetta, Dalila Mele, Andrea Lombardi, Barbara Oliviero, Stefania Mantovani, Carmine Tinelli, Marta Spreafico, Daniele Prati, Serena Ludovisi, Giovanna Ferraioli et al. · 2015 · Gut
3. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN
   Qiang Li, Xiaojing Ren, Chuan Lu, Weixia Li, Yuxian Huang, Liang Chen · 2017 · Medicine
4. Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study
   Tatsuya Ide, Hironori Koga, Masahito Nakano, Satoru Hashimoto, Hiroshi Yatsuhashi, Nobito Higuchi, Makoto Nakamuta, Satoshi Oeda, Yuichiro Eguchi, Satoshi Shakado et al. · 2019 · Hepatology International
5. Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct‑acting antiviral treatment: All Kagawa Liver Disease Group Study
   Joji Tani, Asahiro Morishita, Teppei Sakamoto, Kei Takuma, M. Nakahara, Koji Fujita, Kyoko Oura, Tomoko Tadokoro, Shima Mimura, Takako Nomura et al. · 2020 · Oncology Letters
6. A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies
   Joshua Levy, Nasim Azizgolshani, Michael J. Andersen, Arief Antonius Suriawinata, Xiaoying Liu, Mikhail Lisovsky, Bing Ren, Carly A. Bobak, Brock C. Christensen, Louis Joseph Vaickus · 2020 · Modern Pathology
7. High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective
   Claudia Hawkins, Jennifer L. Grant, Lauren R. Ammerman, Frank Joseph Palella, Milena M. McLaughlin, Richard R. Green, Donna V McGregor, Valentina Stosor · 2016 · Journal of Antimicrobial Chemotherapy
8. Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition)
   Lieming Xu, Ping Liu · 2020 · Journal of Chinese Integrative Medicine
9. Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID‐19 Infection
   Zobair M. Younossi, Maria Stepanova, Brian P Lam, Rebecca Cable, Sean C. Felix, Thomas Jeffers, Elena Younossi, Huong Pham, Manirath K. Srishord, Patrick W. Austin et al. · 2021 · Hepatology Communications
10. Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population
    Satoko Takahashi, Marenao Tanaka, Yukimura Higashiura, Kazuma Mori, Nagisa Hanawa, Hirofumi Ohnishi, Masato Furuhashi · 2021 · Endocrine Journal
11. Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue‐specific insulin sensitivity in patients with early‐stage type 2 diabetes with non‐alcoholic fatty liver disease: A prospective randomized study
    Shigenori Hiruma, Fumika Shigiyama, Naoki Kumashiro · 2023 · Diabetes Obesity and Metabolism
12. Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium
    Kathryn Jane Fowler, Sudhakar Kundapur Venkatesh, Nancy A. Obuchowski, Michael S. Middleton, Jun Chen, Kay M. Pepin, Jessica Magnuson, Kathy J Brown, Danielle Batakis, Walter C. Henderson et al. · 2023 · Radiology
13. Fatty liver index in polycystic ovary syndrome
    Elisabeth Lerchbaum, Hans‐Jürgen Gruber, Verena Theiler‐Schwetz, Albrecht Giuliani, Reinhard Möller, Thomas Rudolf Pieber, Barbara Maria Obermayer-Pietsch · 2011 · European Journal of Endocrinology
14. Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease
    Sander Lefere, Frederique Van de Velde, Lindsey Devisscher, Marlies Bekaert, Sarah Raevens, Xavier Verhelst, Yves Van Nieuwenhove, Marleen M. Praet, Anne Hoorens, Christophe Van Steenkiste et al. · 2017 · International Journal of Obesity
15. Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia
    Namyoung Paik, Dong Hyun Sinn, Ji Hae Lee, In Soo Oh, Jung Hee Kim, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon‐Hyung Lee et al. · 2017 · Liver International
16. Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection
    Zhujun Cao, Ziqiang Li, Hui Wang, Yuhan Liu, Yumin Xu, Ruidong Mo, Peipei Ren, Lichang Chen, Jie Li Lu, Hong Li et al. · 2017 · Liver International
17. Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
    Jason C. Simeone, Jay Patrick Bae, Byron J. Hoogwerf, Qian Li, Axel Haupt, Ayad K. Ali, Marilyn K. Boardman, Beth L. Nordstrom · 2017 · Clinical Epidemiology
18. A sequential algorithm combining ADAPT and liver stiffness can stage metabolic-associated fatty liver disease in hospital-based and primary care patients
    Eslam, Mohammed, Wong, Grace Lai-Hung, Hashem, Ahmed M., Chan, Henry Lik-Yuen, Nielsen, Mette Juul, Leeming, Diana Julie, Chan, Anthony Wing-Hung, Chen, Yu, Duffin, Kevin L., Karsdal, Morten et al. · 2021 · American Journal of Gastroenterology
19. Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline
    Keyur Patel, Sumeet K. Asrani, Maria Isabel Fiel, Deborah Levine, Daniel H. Leung, Andrés Duarte‐Rojo, Jonathan A. Dranoff, Tarek Nayfeh, Bashar Hasan, Tamar Hamosh Taddei et al. · 2024 · Hepatology
20. Head‐to‐Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD : A Prospective Study
    Federica Tavaglione, Maral Amangurbanova, Alexander H. Yang, Monica A. Tincopa, Veeral H. Ajmera, Lisa Richards, Christian Butcher, Christie Hernandez, Egbert V. Madamba, Seema Singh et al. · 2025 · Alimentary Pharmacology & Therapeutics
21. Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis
    Eun Ju Cho, Moon Young Kim, Jeong‐Hoon Lee, Il Young Lee, Yoo Li Lim, Dae Hee Choi, Yoon Jun Kim, Jung‐Hwan Yoon, Soon Koo Baik · 2015 · PLoS ONE
22. Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients
    Nobuharu Tamaki, Masayuki Kurosaki, Shuya Matsuda, Masaru Muraoka, Yutaka Yasui, Shōko Suzuki, Takanori Hosokawa, Ken Ueda, Kaoru Tsuchiya, Hiroyuki Nakanishi et al. · 2013 · Journal of Gastroenterology
23. Advances in the management of HIV/HCV coinfection
    Mattias Mandorfer, Philipp Schwabl, Sebastian Steiner, Thomas Reiberger, Markus Peck‐Radosavljevic · 2016 · Hepatology International
24. Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics
    Eva Jennifer Edelman, Nathan B. Hansen, Christopher J. Cutter, Cheryl Danton, Lynn E. Fiellin, Patrick G. O’Connor, Emily C. Williams, Stephen A. Maisto, KENDALL J. BRYANT, David A. Fiellin · 2016 · Addiction Science & Clinical Practice
25. Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis
    H. Nina Kim, Robin M. Nance, Stephen E. Van Rompaey, Joseph A. Delaney, Heidi M. Crane, Edward R. Cachay, Elvin Hsing Geng, Stephen Boswell, Benigno A. Rodriguez, Joseph J. Eron et al. · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
26. Serum Wisteria floribunda agglutinin‐positive human Mac‐2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection
    Yuki Ichikawa, Satoru Joshita, Takeji Umemura, Yugo Shobugawa, Yoko Usami, Soichiro Shibata, Tomoo Yamazaki, Naoyuki Fujimori, Michiharu Komatsu, Akihiro Matsumoto et al. · 2016 · Hepatology Research
27. Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis
    Suzanne E. Mahady, Petra Macaskill, Jonathan C. Craig, Grace Lai‐Hung Wong, Chiu‐Wing Winnie Chu, Henry Lik‐Yuen Chan, Jacob George, Vincent Wai‐Sun Wong · 2017 · Clinical Gastroenterology and Hepatology
28. Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease
    Hirohito Takeuchi, Katsutoshi Sugimoto, Hisashi Oshiro, Kunio Iwatsuka, Shin Kono, Yu Yoshimasu, Yoshitaka Kasai, Yoshihiro Furuichi, Kentaro Sakamaki, Takao Itoi · 2017 · Journal of Medical Ultrasonics
29. Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection
    Guoxiang Xie, Xiaoning Wang, Runmin Wei, Jingye Wang, Aihua Zhao, Tianlu Chen, Yixing Wang, Hua Zhang, Zhun Xiao, Xinzhu Liu et al. · 2020 · BMC Medicine
30. Characteristics of hepatocellular carcinoma arising from Fontan‐associated liver disease
    Takaomi Sagawa, Tomomi Kogiso, Hisashi Sugiyama, Etsuko Hashimoto, Masakazu Yamamoto, Katsutoshi Tokushige · 2020 · Hepatology Research
31. A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
    Mikal Jacob Hole, Kristin Kaasen Jørgensen, Kristian Holm, Peder R. Braadland, Malin Holm Meyer‐Myklestad, Asle W. Medhus, Dag Henrik Reikvam, Alexandra Götz, Krzysztof Grzyb, Kirsten Muri Boberg et al. · 2022 · Hepatology
32. Cause-specific mortality in patients with steatotic liver disease in the United States
    Pedro Ochoa‐Allemant, Rebecca A. Hubbard, David E. Kaplan, Marina Serper · 2025 · Journal of Hepatology
33. Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice
    Andrés Duarte‐Rojo, José Altamirano, Jordan J. Feld · 2012 · Annals of Hepatology
34. Supersonic Shear Imaging and Transient Elastography With the XL Probe Accurately Detect Fibrosis in Overweight or Obese Patients With Chronic Liver Disease
    Masato Yoneda, Emmanuel Thomas, Seth N. Sclair, Tiffannia T. Grant, Eugene R. Schiff · 2015 · Clinical Gastroenterology and Hepatology
35. High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease
    Huang‐Wei Xu, Yung‐Chien Hsu, Chia‐Hao Chang, Kuo‐Liang Wei, Chun‐Liang Lin · 2015 · Hepatology International
36. MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C
    Kevin Appourchaux, Safi Dokmak, Matthieu Resche‐Rigon, Xavier Tréton, Martine Lapalus, Charles‐Henry Gattolliat, Emmanuelle Porchet, Michelle Martinot-Peignoux, Nathalie Boyer, Michel Vidaud et al. · 2016 · Scientific Reports
37. Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options
    Bubu A. Banini, Arun Jayant Sanyal · 2016 · Clinical Medicine Insights Therapeutics
38. Diagnostic performance of quantitative magnetic resonance imaging biomarkers for predicting portal hypertension in children and young adults with autoimmune liver disease
    Jonathan R. Dillman, Suraj D. Serai, Andrew T. Trout, Ruchi Singh, Jean A. Tkach, Amy E. Taylor, Burns C. Blaxall, Lin Fei, Alexander Gerhard Miethke · 2019 · Pediatric Radiology
39. Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes
    Jia Li, Stuart C. Gordon, Loralee B. Rupp, Talan Zhang, Sheri Trudeau, Scott D. Holmberg, Anne C. Moorman, Philip R. Spradling, Eyasu H. Teshale, Joseph A. Boscarino et al. · 2019 · Alimentary Pharmacology & Therapeutics
40. Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases
    Nobuharu Tamaki, Masayuki Kurosaki, Rohit Seth Loomba, Namiki Izumi · 2020 · Annals of Laboratory Medicine
41. Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes
    Hiroshi Ishiba, Yoshio Sumida, Yuya Seko, Saiyu Tanaka, Masato Yoneda, Hideyuki Hyogo, Masafumi Ono, Hideki Fujii, Yuichiro Eguchi, Yasuaki Suzuki et al. · 2020 · Hepatology Communications
42. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
    Lampros Chrysavgis, Eleftheria Ztriva, Adonis A Protopapas, Κωνσταντίνος Τζιόμαλος, Εvangelos Cholongitas · 2020 · World Journal of Gastroenterology
43. Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials
    Cheng Han Ng, Snow Yunni Lin, Yip Han Chin, Ming Hui Lee, Nicholas L. X. Syn, Xin Lei Goh, Jin Hean Koh, Jingxuan Quek, Darren Jun Hao Tan, Shao Feng Mok et al. · 2021 · Endocrine Practice
44. Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
    Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, Nor Azian Abdul Murad · 2021 · Biomedicines
45. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: A comparative study
    Shengdi Wu · 2010 · World Journal of Gastroenterology
46. NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b
    Eiichi Ogawa, Norihiro Furusyo, Hideyuki Nomura, Kazufumi Dohmen, Nobuhiko Higashi, Kazuhiro Takahashi, Akira Kawano, Koichi Azuma, Takeaki Satoh, Makoto Nakamuta et al. · 2016 · Journal of Gastroenterology
47. Mean platelet volume and platelet to lymphocyte count ratio are associated with hepatitis B-related liver fibrosis
    M. A. Kosekli · 2021 · European Journal of Gastroenterology and Hepathology
48. Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model
    Anahita Rabiee, Yanhong Deng, Maria M. Ciarleglio, Jean L. Chan, Mònica Pons, Joan Genescà, Guadalupe García–Tsao · 2022 · Hepatology Communications
49. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank
    Theresa Hydes, Oliver John Kennedy, Ryan Malcolm Buchanan, Daniel James Cuthbertson, Julie Parkes, Simon DS Fraser, Paul J. Roderick · 2023 · BMC Medicine
50. Noninvasive tests for liver fibrosis in 2024: are there different scales for different diseases?
    Jimmy Che‐To Lai, Lilian Yan Liang, Grace Lai‐Hung Wong · 2023 · Gastroenterology report
51. Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort
    Joo Hyun Oh, Seon Cho, Seon Cho, Eun‐Hee Nah, Eileen Laureal Yoon, Dae Won Jun · 2024 · Journal of Hepatology
52. Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease
    Theodore T. Pierce, Arinc Ozturk, Sarah P. Sherlock, Guilherme Moura Cunha, X J Wang, Qian Li, David D. Hunt, Michael S. Middleton, Marian Martin, Kathleen E. Corey et al. · 2024 · Radiology
53. Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study
    Katrine Prier Lindvig, Katrine Holtz Thorhauge, Johanne K Hansen, Maria Kjærgaard, Camilla Dalby Hansen, Stine Johansen, Ellen Lyngbeck Jensen, Mads Egerod Israelsen, Peter Andersen, K. Bech et al. · 2024 · The Lancet. Gastroenterology & hepatology
54. High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013
    Helen Kovari, Bruno Ledergerber, Matthias L. Cavassini, Juan Ambrosioni, Andrea Bregenzer, M Stöckle, Enos Bernasconi, Roger D. Kouyos, Rainer K. Weber, Andri Rauch · 2015 · Journal of Hepatology
55. Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study
    María José Morlán-Coarasa, M. Arias, Víctor Ortiz‐García de la Foz, Obdulia Martínez‐García, Carmen Alonso-Martín, Javier Crespo, Manuel Romero‐Gómez, Emilio Fábrega, Benedicto Crespo‐Facorro · 2016 · Psychopharmacology
56. Comparative evaluation of GPR versus APRI and FIB‐4 in predicting different levels of liver fibrosis of chronic hepatitis B
    Danping Liu, Wei Lu, Zhanqing Zhang, Yun‐Jing Wang, Rongrong Ding, Xiaohui Zhou, Dan Feng Huang, X.‐F. Li · 2017 · Journal of Viral Hepatitis
57. Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography
    Nikolaos Papadopoulos · 2019 · Annals of Gastroenterology
58. Lymphocyte-To-Monocyte Ratio as the Best Simple Predictor of Bacterial Infection in Patients with Liver Cirrhosis
    Damian Piotrowski, Anna Sączewska-Piotrowska, Jerzy Jaroszewicz, Anna Boroń‐Kaczmarska · 2020 · International Journal of Environmental Research and Public Health
59. Changes in Background Liver Function in Patients with Hepatocellular Carcinoma over 30 Years: Comparison of Child-Pugh Classification and Albumin Bilirubin Grade
    Takashi Kumada, Hidenori Toyoda, Toshifumi Tada, Satoshi Yasuda, Junko Tanaka · 2020 · Liver Cancer
60. Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD
    Canivet, Clémence M., Costentin, Charlotte, Irvine, Katharina M., Delamarre, Adèle, Lannes, Adrien, Sturm, Nathalie, Oberti, Frederic, Patel, Preya J., Decaens, Thomas, Irles‐Depé, Marie et al. · 2023 · Hepatology
61. Statins’ efficacy in non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Chrysoula Boutari, Panagiotis D. Pappas, Dimitrios A. Anastasilakis, Christos Socrates Mantzoros · 2022 · Clinical Nutrition
62. Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis
    Ana María Gómez‐Pérez, Patricia Ruiz‐Limón, Jordi Salas‐Salvadó, Jesús Vioqué, Dolores Corella, Montserrat Fitó, Josép Vidal, Alessandro Atzeni, Laura Torres Collado, Andrea Álvarez‐Sala et al. · 2023 · Gut Microbes
63. Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
    Angelo Armandi, Tiziana Sanavia, Ramy Younes, Gian Paolo Caviglia, Chiara Rosso, Olivier Govaere, Antonio Liguori, Paolo Francione, Rocío Gallego‐Durán, Javier Ampuero et al. · 2024 · Gut
64. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation
    Waqar Ahmad, Bushra Ijaz, Sana Gull, Sultan Asad, Saba Khaliq, Shah Jahan, Muhammad Tahir Sarwar, Humera Kausar, Aleena Sumrin, Imran Shahid et al. · 2011 · Virology Journal
65. Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus‐Infected U.S. Women
    Mark H. Kuniholm, Edgar Ong, Boris M. Hogema, Marco Koppelman, Kathryn Anastos, Marion G. Peters, Eric C. Seaberg, Yue Chen, Kenrad E. Nelson, Jeffrey M. Linnen · 2015 · Hepatology
66. Metabolic‐associated fatty liver disease (MAFLD) in coeliac disease
    Antonio Rispo, Nicola Imperatore, Maria Guarino, Raffaella Tortora, Anna Alisi, Valentina Cossiga, Anna Testa, Simona Ricciolino, Andrea Fiorentino, Filomena Morisco · 2020 · Liver International
67. Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
    Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Seungbong Han, Young‐Suk Lim · 2022 · Journal of Clinical Investigation
68. SGLT2 inhibitor treatment outcome in nonalcoholic fatty liver disease complicated with diabetes mellitus: the long-term effects on clinical features and liver histopathology
    Akuta, Norio, Kawamura, Yusuke, Fujiyama, Shunichiro, Sezaki, Hitomi, Hosaka, Tetsuya, Kobayashi, Masahiro, Kobayashi, Mariko, Saitoh, Satoshi, Suzuki, Fumitaka, Suzuki, Yoshiyuki et al. · 2020 · Internal Medicine
69. Meta-analysis: enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases
    Hinkson, Alexander, Lally, Hannah, Gibson, Hannah, Jones, Rebecca, Rowe, Ian A., Shinkins, Bethany, Parker, Richard · 2023 · Alimentary Pharmacology & Therapeutics
70. Towards an adiposity-related disease framework for the diagnosis and management of obesities
    Carolina María Perdomo, Icíar Avilés-Olmos, Dror Dicker, Gema Frühbeck · 2023 · Reviews in Endocrine and Metabolic Disorders
71. Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels
    Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Masato Yoneda, Kento Imajo, Yuichiro Eguchi, Hideki Fujii, Yoshio Sumida, Hideyuki Hyogo, Masafumi Ono, Yasuaki Suzuki, Takumi Kawaguchi et al. · 2012 · Journal of Gastroenterology
72. Non-invasive serum fibrosis markers: A study in chronic hepatitis
    Mohammadreza Abdollahi, Ali Asghar Pouri, Morteza Ghojazadeh, Rasoul Estakhri, Mohammad Hossein Somi · 2015 · Bioimpacts
73. Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer
    Yachana Kataria, Ryan Deaton, Erika Enk, Ming Li Jin, Milita Petrauskaite, Linlin Dong, Joseph R. Goldenberg, Scott J. Cotler, Donald M. Jensen, Richard Bruce van Breemen et al. · 2016 · BMC Gastroenterology
74. Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease
    Vaishali A. Patel, Arun Jayant Sanyal, Richard K. Sterling · 2016 · Clinics in Liver Disease
75. Use of Mac‐2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis
    Yoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, Hideki Fujii, Yoshio Sumida, Makoto Yamada, Kojiroh Mori, Saiyu Tanaka, Tomohiro Maekawa, Yusuke Ebisutani et al. · 2017 · Hepatology Communications
76. MRI‐defined sarcopenia predicts mortality in patients with chronic liver disease
    Lucian Beer, Nina Bastati, Ahmed Ba‐Ssalamah, Sarah Pötter-Lang, Katharina Lampichler, Yesim Bican, David A. Lauber, Jacqueline C. Hodge, Teresa Binter, Katharina Pomej et al. · 2020 · Liver International
77. Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan
    for the LUCID study investigators, Ryosuke Tateishi, Takeshi Matsumura, Takeshi Okanoue, Toshihide Shima, Koji Uchino, Naoto Fujiwara, Takafumi Senokuchi, Kazuyoshi Kon, Takayoshi Sasako et al. · 2021 · Journal of Gastroenterology
78. Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
    Daryl Ramai, Antonio Facciorusso, Erika Vigandt, Bryan Schaf, Waleed Saadedeen, Aditya Chauhan, Sara di Nunzio, Aashni Shah, Luca Giacomelli, Rodolfo Sacco · 2021 · Cells
79. Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Luis A. Rodríguez, Julie A. Schmittdiel, Liyan Liu, Brock A. Macdonald, Sreepriya Balasubramanian, Krisna P. Chai, Suk Seo, Nizar A. Mukhtar, Theodore R. Levin, Varun Saxena · 2024 · JAMA Network Open
80. Atherosclerosis risk in HIV-infected patients: The influence of hepatitis C virus co-infection
    Philippe Sosner, Marc Wangermez, Carine Chagneau-Derrode, Gwenael Le Moal, Christine Silvain · 2012 · Atherosclerosis
81. AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C
    Fatih Güzelbulut, Züleyha Akkan Çetinkaya, Mesut Sezikli, Selvinaz Özkara, Oya Övünç Kurdaş, Bülent Yaşar · 2011 · The Turkish Journal of Gastroenterology
82. Performance of non‐invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non‐alcoholic fatty liver disease
    Mohammad Shadab Siddiqui, Kavish Rohit Patidar, Sherry L. Boyett, Velimir A. Luketic, Puneet Puri, Arun Jayant Sanyal · 2015 · Liver International
83. Data Mining and Machine Learning Algorithms Using IL28B Genotype and Biochemical Markers Best Predicted Advanced Liver Fibrosis in Chronic Hepatitis C
    Hend Ibrahim Shousha, Abubakr Awad, Dalia Omran, Mayada Elnegouly, Mahasen Mabrouk · 2017 · Japanese Journal of Infectious Diseases
84. Race and Hepatitis C Care Continuum in an Underserved Birth Cohort
    Nicole J. Kim, Cameron J. Locke, Helen Park, Catherine Magee, Peter Bacchetti, Mandana Khalili · 2018 · Journal of General Internal Medicine
85. The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: A systematic review and meta-analysis
    Yuanqiang Lin, Hequn Li, Chunxiang Jin, Hui Wang, Bo Jiang · 2020 · PLoS ONE
86. Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non‐invasive tests for the diagnosis of advanced liver fibrosis in patients with non‐alcoholic fatty liver disease
    Chika Inadomi, Hirokazu Takahashi, Yuji Ogawa, Satoshi Oeda, Kento Imajo, Yoshihito Kubotsu, Kenichi Tanaka, Takaomi Kessoku, Michiaki Okada, Hiroshi Isoda et al. · 2020 · Hepatology Research
87. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease
    Rohit Sinha, Khalida Ann Lockman, Natalie Z M Homer, Edward Kenneth Merrick Bower, Paul Brinkman, Hugo Knobel, Jonathan Andrew Fallowfield, Alan J. Jaap, Peter Clive Hayes, John N. Plevris · 2020 · JHEP Reports
88. Relationships between education and non-alcoholic fatty liver disease
    Koutny, Florian, Aigner, Elmar, Datz, Christian, Gensluckner, Sophie, Maieron, Andreas, Mega, Andrea, Iglseder, Bernhard, Langthaler, Patrick, Frey, Vanessa, Paulweber, Bernhard et al. · 2023 · European Journal of Internal Medicine
89. Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures
    Hiroshima Liver Study Group, Mitsutaka Osawa, Michio Imamura, Yuji Teraoka, Takuro Uchida, Kei Morio, Hatsue Fujino, Takashi Nakahara, Atsushi Ono, Eisuke Murakami et al. · 2018 · Journal of Gastroenterology
90. The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
    Yasser Mahrous Fouad, Gamal Esmat, Reda Elwakil, Serag Zakaria, Ayman Yosry, Imam A. Waked, Maissa El-Razky, Wahid H. Doss, Magdy El‐Serafy, Ebraheem Mostafa et al. · 2022 · Saudi Journal of Gastroenterology
91. Association of systemic immune biomarkers with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study of NHANES 2007–2018
    Yong Wang, Shude Chen, Chen Tian, Qi Wang, Zhihua Yang, Wieqi Che, Yike Li, Yang Luo · 2024 · Frontiers in Nutrition
92. Adverse Liver Outcomes, Cardiovascular Events, and Mortality in Steatotic Liver Disease
    Pedro Ochoa‐Allemant, Rebecca A. Hubbard, David E. Kaplan, Marina Serper · 2025 · JAMA Internal Medicine
93. Simultaneous Population Pharmacokinetic Model for Lopinavir and Ritonavir in HIV-Infected Adults
    José Moltó, M.J. Barbanoj, Cristina Miranda, Asunción Blanco, José Ramón Santos, Eugènia Negredo, Joan Costa, Peré Domingo, Bonaventura Clotet, Marta Valle · 2008 · Clinical Pharmacokinetics
94. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis
    Kiran M. Bambha, Christopher B. Pierce, Christopher Cox, Audrey L. French, Phyllis C. Tien, Gerald B. Sharp, Michael H. Augenbraun, Marshall Jay Glesby, Maria C. Villacres, Michael W Plankey et al. · 2011 · AIDS
95. Clinical significance of serum Wisteria floribunda agglutinin positive Mac‐2‐binding protein level in non‐alcoholic steatohepatitis
    Hiroki Nishikawa, Hirayuki Enomoto, Yoshinori Iwata, Kyohei Kishino, Yoshihiro Shimono, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Kazunori Yoh, Takashi Nishimura et al. · 2016 · Hepatology Research
96. Red Blood Cell Distribution Width to Platelet Ratio is Related to Histologic Severity of Primary Biliary Cirrhosis
    Huan Wang, Hongqin Xu, Xiaomei Wang, Ruihong Wu, Xiuzhu Gao, Qinglong Jin, Junqi Niu · 2016 · Medicine
97. Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis
    Sherief Mohamed Abd-Elsalam, Eslam Habba, Walaa Ahmed Elkhalawany, Salwa Tawfeek, Hasan ElSayed El-Batea, Ferial El-Kalla, Hanan Hamed Soliman, Samah Mosaad Soliman, Mohamed Yousef, Abdelrahman Abdelraouf Kobtan et al. · 2016 · Medicine
98. Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections
    Daniel Fuster, Arantza Sanvisens, Ferrán Bolao, Inmaculada Rivas, Jordi Tor, Roberto Muga · 2016 · World Journal of Hepatology
99. Incidence, determinants and outcomes of pregnancy‐associated hepatitis B flares: A regional hospital‐based cohort study
    Tatyana Kushner, Pamela A. Shaw, Ankush Kalra, Lora Magaldi, Pooja Monpara, Gurneet Bedi, Karen L. Krok, Sierra Centkowski, Katherine Dalldorf, Julia C. D'Souza et al. · 2017 · Liver International
100. Evaluation and comparison of thirty noninvasive models for diagnosing liver fibrosis in chinese hepatitis B patients
     Xiaoqin Dong, Zhao Wu, Hong Zhao, Gui‐Qiang Wang · 2018 · Journal of Viral Hepatitis